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Background
Multiple Sclerosis (MS) is considered to be an autoim-
mune disease with unknown cause and with immune
system dysregulation. Among environmental factors,
viruses are most often connected with the etiology of
MS.
Human Endogenous Retroviruses (HERVs) constitute
5-8% of human genomic DNA and have been detected
as transcripts and proteins in the central nervous system
(CNS) and peripheral blood, frequently in the context of
neuro inflammation [1,2].
In our recent genetic epidemiology study in MS
patients [3] we found indications of a specific genetic
association between HERV-Fc1 (which belongs to the
HERV-H/F family) and MS. One marker neighboring
HERV-Fc1 (rs391745) had a p-value of 1.3x10-6 for dis-
ease association in a trend test.
Materials and methods
Using polyclonal rabbit antibodies raised against a Gag
peptide, conserved in the HERV-H/F family, the authors
studied the expression of a capsid protein of HERV-H/F
origin by flow cytometry in PBMCs from healthy con-
trols and from MS patients with non-active or active
disease. Furthermore, we have undertaken the first rig-
orous SYBR green-based absolute Q-PCR evaluation
approach to quantify extracellular HERV-Fc1 RNA viral
loads in plasma from patients with MS and healthy
controls.
Results
We showed significant differences in the expression of
HERV-H/F Gag protein epitopes between PBMCs from
healthy controls and from MS patients. We found
higher HERV-H/F Gag expression in peripheral blood
CD19+ cells and significantly higher expression in
monocytes in patients with non-active MS than in
healthy controls. For patients with active MS, much
higher differences in the HERV-H/F Gag expression
relative to healthy controls were detected for CD4+ and
CD8+ T cells indicating that this HERV family may play
a role in the extensive activation of the innate and adap-
tive immune responses in MS. Also for patients with
active MS, the expression of HERV-H/F Gag by CD4+
T cells was significantly higher than that by CD8a+ T
cells.
Extracellular HERV-Fc1 RNAs were detected in
plasma samples from both healthy controls and from
MS patients. In plasma samples from patients with non-
active MS, higher levels of extracellular HERV-Fc1
RNAs were found as compared with healthy controls.
Moreover, a 5-fold increase of the amount of extracellu-
lar HERV-Fc1 RNA was found in plasma samples from
patients with active MS as compared with healthy
controls.
Conclusions
These findings strengthen the link between HERV-Fc1
and the pathology of MS. The cause and biological con-
sequences of these differential expressions will be the
subject of further investigation. HERV-Fc1 biology could
be a compelling area for understanding the pathology of
MS and possibly other autoimmune disorders.
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